Clinical characteristics and disease course in patients treated with efalizumab following suspension of marketing authorization by the European Medicines Agency: A multicenter observational study
- Morell, L.
- Carrascosa, J.M.
- Ferrándiz, C.
- García-Bustinduy, M.
- Fonseca, E.
- Carretero, G.
- Daudén, E.
- Marrón, S.E.
- López-Estebaranz, J.L.
- Ferrán, M.
- Sánchez-Regaña, M.
- Muñoz-Santos, C.
- Belinchón, I.
- Puig, L.
ISSN: 1578-2190, 0001-7310
Datum der Publikation: 2011
Ausgabe: 102
Nummer: 5
Seiten: 354-364
Art: Artikel